ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR.
Saved in:
| Title: | ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR. |
|---|---|
| Authors: | Di Lecce C; Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy., Eccher S; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and Verona University Hospital Trust, Verona, Italy., Simbolo M; Surgical Pathology Unit, Verona University Hospital Trust, Verona, Italy., Cocomazzi A; Surgical Pathology Unit, Verona University Hospital Trust, Verona, Italy., Piredda ML; Surgical Pathology Unit, Verona University Hospital Trust, Verona, Italy., Caliò A; Surgical Pathology Unit, Verona University Hospital Trust, Verona, Italy; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy., Cima L; Surgical Pathology Unit, Verona University Hospital Trust, Verona, Italy., Munari E; Surgical Pathology Unit, Verona University Hospital Trust, Verona, Italy., Veronese N; Saint Camillus International University of Health Sciences, Rome, Italy., Avancini A; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and Verona University Hospital Trust, Verona, Italy., Zanconati F; Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy., Milella M; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and Verona University Hospital Trust, Verona, Italy., Scarpa A; Surgical Pathology Unit, Verona University Hospital Trust, Verona, Italy; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy; Arc-Net Research Center, University of Verona, Verona, Italy., Pilotto S; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and Verona University Hospital Trust, Verona, Italy., Belluomini L; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and Verona University Hospital Trust, Verona, Italy., Luchini C; Surgical Pathology Unit, Verona University Hospital Trust, Verona, Italy; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy; Arc-Net Research Center, University of Verona, Verona, Italy. Electronic address: claudio.luchini@univr.it. |
| Source: | Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Jul; Vol. 205, pp. 108594. Date of Electronic Publication: 2025 Jun 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
